Graves Light Lenhart Wealth’s Definium Therapeutics DFTX Stock Holding History

Graves Light Lenhart Wealth’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19	Closed	–	–	410
2022 Q2	$0	Buy	+19	New	+$240	﹤0.01%	669

Other funds holding DFTX

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Graves Light Lenhart Wealth's DFTX Position: Q3 2022 in Review

Graves Light Lenhart Wealth sold out of Definium Therapeutics (DFTX) in Q3 2022, closing a stake of 19 shares.

Graves Light Lenhart Wealth first reported a position in DFTX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 101 funds tracked by Wall St. Rank hold DFTX as of Q3 2022.

Graves Light Lenhart Wealth reported no remaining Definium Therapeutics position as of Q3 2022 after selling out during the quarter.
Graves Light Lenhart Wealth sold 19 Definium Therapeutics shares in Q3 2022.
Graves Light Lenhart Wealth first reported a position in Definium Therapeutics in Q2 2022 and held it in 1 quarter.
Graves Light Lenhart Wealth's Definium Therapeutics position peaked at $0 in Q2 2022.
101 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2022.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.